Department of Clinical Laboratory Medicine, Suining Central Hospital, 127 Deshengxi Rd., Suining, 629000, Sichuan, People's Republic of China.
Department of Public Health Administration and Health Education, Suining Central Hospital, Suining, 629000, Sichuan, People's Republic of China.
Environ Sci Pollut Res Int. 2022 Feb;29(9):13720-13728. doi: 10.1007/s11356-021-16786-y. Epub 2021 Oct 1.
Air pollution is a critical risk factor for the prevalence of COVID-19. However, few studies have focused on whether air pollution affects the efficacy of the SARS-CoV-2 vaccine. To better guide the knowledge surrounding this vaccination, we conducted a cross-section study to identify the relationships between air pollutant exposure and plasma neutralizing antibody (NAb) titers of an inactivated SARS-CoV-2 vaccine (Vero cell, CoronaVac, SINOVΛC, China). We recruited 239 healthcare workers aged 21-50 years who worked at Suining Central Hospital. Of these, 207 were included in this study, depending on vaccination date. The data regarding air pollutants were collected to calculate individual daily exposure dose (DED). The geometric mean of all six pollutant DEDs was applied to estimate the combined toxic effects (DED). Then, the participants were divided into two groups based on the mean value of DED. The median plasma NAb titer was 12.81 AU/mL, with 85.99% vaccine efficacy in healthcare workers against SARS-CoV-2. In exposure group, observations included lower plasma NAb titers (median: 11.13 AU/mL vs. 14.56 AU/mL), more peripheral counts of white blood cells and monocytes (mean: 6.71 × 10/L vs. 6.29 × 10/L and 0.49 × 10/L vs. 0.40 × 10/L, respectively), and a higher peripheral monocyte ratio (7.38% vs. 6.50%) as compared to the reference group. In addition, elevated air pollutant DEDs were associated with decreased plasma NAb titers. To our knowledge, this study is the first to report the relationship between air pollutant exposure and plasma NAb titers of the SARS-CoV-2 vaccine. This suggests that long-term exposure to air pollutants may inhibit plasma NAb expression by inducing chronic inflammation. Therefore, to achieve early herd immunity and hopefully curb the COVID-19 epidemic, vaccinations should be administered promptly to those eligible, and environmental factors should be considered as well.
空气污染是 COVID-19 流行的一个关键危险因素。然而,很少有研究关注空气污染是否会影响 SARS-CoV-2 疫苗的效果。为了更好地指导围绕这种疫苗接种的知识,我们进行了一项横断面研究,以确定空气污染物暴露与灭活 SARS-CoV-2 疫苗(Vero 细胞,科兴中维,SINOVΛC,中国)的血浆中和抗体(NAb)滴度之间的关系。我们招募了 239 名年龄在 21-50 岁之间在遂宁市中心医院工作的医护人员。根据接种日期,其中 207 人纳入了本研究。收集了有关空气污染物的数据以计算个体每日暴露剂量(DED)。所有六种污染物 DED 的几何平均值用于估计联合毒性效应(DED)。然后,根据 DED 的平均值将参与者分为两组。医护人员对 SARS-CoV-2 的血浆 NAb 滴度中位数为 12.81 AU/mL,疫苗效力为 85.99%。在暴露组中,观察到较低的血浆 NAb 滴度(中位数:11.13 AU/mL 比 14.56 AU/mL)、外周血白细胞和单核细胞计数增加(均值:6.71×10/L 比 6.29×10/L 和 0.49×10/L 比 0.40×10/L)和外周单核细胞比例升高(7.38%比 6.50%)。此外,空气污染物 DED 升高与血浆 NAb 滴度降低有关。据我们所知,这项研究首次报告了空气污染物暴露与 SARS-CoV-2 疫苗的血浆 NAb 滴度之间的关系。这表明,长期暴露于空气污染物可能通过诱导慢性炎症抑制血浆 NAb 的表达。因此,为了实现早期群体免疫并有望遏制 COVID-19 疫情,应尽快为符合条件的人群接种疫苗,并考虑环境因素。